Wolverine Trading, LLC Abiomed Inc Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $2.71 Million - $3.34 Million	-9,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$310.19 - $376.2 $2.79 Million - $3.39 Million	9,000 New	9,000 $2.97 Million
Q2 2021 Aug 06, 2021	SELL	$262.71 - $351.17 $1.94 Million - $2.6 Million	-7,400 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$285.92 - $355.13 $14 Million - $17.4 Million	-49,100 Reduced 86.9%	7,400 $2.29 Million
Q4 2020 Feb 12, 2021	BUY	$251.88 - $324.2 $75,564 - $97,260	300 Added 0.53%	56,500 $18.3 Million
Q3 2020 Nov 13, 2020	SELL	$255.22 - $317.0 $3.37 Million - $4.18 Million	-13,200 Reduced 19.02%	56,200 $15.3 Million
Q2 2020 Aug 13, 2020	SELL	$141.4 - $257.09 $664,580 - $1.21 Million	-4,700 Reduced 6.34%	69,400 $16.7 Million
Q1 2020 May 11, 2020	SELL	$130.51 - $196.01 $2.83 Million - $4.25 Million	-21,700 Reduced 22.65%	74,100 $11 Million
Q4 2019 Feb 12, 2020	BUY	$159.31 - $223.54 $1.93 Million - $2.7 Million	12,100 Added 14.46%	95,800 $16 Million
Q3 2019 Nov 14, 2019	BUY	$175.89 - $279.23 $123,122 - $195,461	700 Added 0.84%	83,700 $14.7 Million
Q2 2019 Aug 20, 2019	BUY	$250.96 - $284.94 $1.28 Million - $1.45 Million	5,100 Added 6.55%	83,000 $21.6 Million
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $4.75 Million - $6.23 Million	17,200 Added 28.34%	77,900 $22.2 Million
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $11.8 Million - $18.7 Million	-42,000 Reduced 40.9%	60,700 $19.3 Million
Q3 2018 Nov 14, 2018	BUY	$354.53 - $449.75 $24.4 Million - $31 Million	68,900 Added 203.85%	102,700 $46.2 Million
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $6.51 Million - $10 Million	33,800 New	33,800 $9.84 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account